Header

Skip to main content

REGENXBIO

REGENX Biosciences is a biopharmaceutical company that develops therapeutics and research tools based on adeno-associated viral (AAV) vectors.

Primera Therapeutics

Primera Therapeutics focuses on developing gene editing therapies targeting mitochondrial DNA mutations, addressing the root cause of mitochondrial diseases, which can lead to severe childhood diseases, chronic kidney disease, and metabolic disorders.

Charles River

Vigene Biosciences was founded in 2012 by senior scientists with expertise in the fields of virology and gene therapy, and strives to be the leading supplier of gene delivery technologies with the mission to advance biomedical research and to make gene therapy affordable.

Addimmune

Addimmune is a clinical-stage gene and cell therapy company developing a functional cure for HIV. It is developing a single-dose lentiviral-based autologous cell therapy.

This website uses cookies

This site uses cookies to provide more personalized content, social media features, and ads, and to analyze our traffic. We might share information about your use of our site with our social media, advertising, and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. We will never sell your information or share it with unaffiliated entities.